The decline loses momentum: CMF turns positive and momentum near zero
Procter & Gamble is at week 12 of a sell signal. Over the past 4 weeks the decline has progressively lost momentum: CMF back in positive territory, momentum near zero, MACD histogram sharply converging. The confirmation week closed up 2.1%.
Pfizer — four weeks of waiting: the decline has not yet confirmed
Pfizer is at week 4 of a sell signal that has not yet confirmed: three sideways weeks after the initial drop, with a daily double bottom in the 25 area and CMF still negative but gradually recovering.
PepsiCo: decline holds, but momentum is easing
PepsiCo is at week 11 of the sell signal. MACD has crossed into negative territory, CMF remains in distribution: the decline holds, but the weekly drop has eased compared to the prior week.
Week 10: The Decline Fades, Confirmation Points to Exit
PG&E Corporation is at week 10 of a sell signal. The decline holds directionally, but the technical picture over recent weeks points to a progressive fade: buyers back in control, momentum recovering, CMF improving.
Petroleo Brasileiro: sell signal, but context limits new entries
Fresh sell signal on Petroleo Brasileiro SA Sponsored ADR, ranking 17th among 96 sell signals on US stocks. The weekly structure is bearish, but the quality band flags trading as not recommended: the stock remains 26% above the 200-week moving average.
Palo Alto Networks: model coverage done, 40% runner meets its first pullback
At week 12 and up 62% from entry, Palo Alto Networks has completed model coverage. The 40% runner continues with a trailing stop. The week closed down 3.4% with sellers dominant: first pullback after 3 consecutive up weeks.